Cargando…

Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction

The autonomic nervous system (ANS) is a part of the peripheral nervous system that regulates internal organs function at an involuntary unconscious level. Recent evidence has shown that autonomic dysfunction is a common feature of Lewy body dementia (LBD). A wide range of autonomic symptoms may occu...

Descripción completa

Detalles Bibliográficos
Autor principal: Khosravi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274226/
https://www.ncbi.nlm.nih.gov/pubmed/34148337
http://dx.doi.org/10.4081/ejtm.2021.9876
_version_ 1783721520480124928
author Khosravi, Mohsen
author_facet Khosravi, Mohsen
author_sort Khosravi, Mohsen
collection PubMed
description The autonomic nervous system (ANS) is a part of the peripheral nervous system that regulates internal organs function at an involuntary unconscious level. Recent evidence has shown that autonomic dysfunction is a common feature of Lewy body dementia (LBD). A wide range of autonomic symptoms may occur in LBD, which are correlated with poor prognosis. However, there is still no evidence-based approach to developing the best therapeutic strategy for autonomic dysfunction (particularly gastrointestinal symptoms) among LBD patients. This paper was intended to present a new perspective on ursodeoxycholic acid and its potential effects for treating gastrointestinal dysfunction in LBD patients.
format Online
Article
Text
id pubmed-8274226
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-82742262021-07-27 Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction Khosravi, Mohsen Eur J Transl Myol Article The autonomic nervous system (ANS) is a part of the peripheral nervous system that regulates internal organs function at an involuntary unconscious level. Recent evidence has shown that autonomic dysfunction is a common feature of Lewy body dementia (LBD). A wide range of autonomic symptoms may occur in LBD, which are correlated with poor prognosis. However, there is still no evidence-based approach to developing the best therapeutic strategy for autonomic dysfunction (particularly gastrointestinal symptoms) among LBD patients. This paper was intended to present a new perspective on ursodeoxycholic acid and its potential effects for treating gastrointestinal dysfunction in LBD patients. PAGEPress Publications, Pavia, Italy 2021-06-11 /pmc/articles/PMC8274226/ /pubmed/34148337 http://dx.doi.org/10.4081/ejtm.2021.9876 Text en https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Khosravi, Mohsen
Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title_full Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title_fullStr Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title_full_unstemmed Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title_short Lewy body dementia: Ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
title_sort lewy body dementia: ursodeoxycholic acid as a putative treatment for gastrointestinal dysfunction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274226/
https://www.ncbi.nlm.nih.gov/pubmed/34148337
http://dx.doi.org/10.4081/ejtm.2021.9876
work_keys_str_mv AT khosravimohsen lewybodydementiaursodeoxycholicacidasaputativetreatmentforgastrointestinaldysfunction